2CUREX — 2cureX AB Income Statement
0.000.00%
Last trade - 00:00- SEK14.71m
- SEK9.57m
Annual income statement for 2cureX AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | SAS | SAS | SAS | SAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.09 | 0.155 | 0 |
| Cost of Revenue | |||||
| Gross Profit | -10.1 | -11.9 | -12.3 | -12.1 | -3.87 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.42 | 22.8 | 32.2 | 36.5 | 4.74 |
| Operating Profit | -7.42 | -22.8 | -32.1 | -36.4 | -4.74 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -8.59 | -22.5 | -29.8 | -37.1 | -4.13 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -7.32 | -18.9 | -29.8 | -32.5 | -4.13 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -7.32 | -18.9 | -29.8 | -32.5 | -4.13 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -7.32 | -18.9 | -29.8 | -32.5 | -4.13 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.538 | -2.37 | -1.69 | -1.85 | -0.196 |
| Dividends per Share |